Pathwork Releases Three Study Results
Pathwork Diagnostics announced results of a study that indicated that TTF-1 does not correctly identify half of NSCLC cases in patients that present with metastatic or poorly differentiated cancer.
Read MorePosted by Clinical Lab Products | Jun 1, 2012 | Cancer, Miscellaneous |
Pathwork Diagnostics announced results of a study that indicated that TTF-1 does not correctly identify half of NSCLC cases in patients that present with metastatic or poorly differentiated cancer.
Read MorePosted by Clinical Lab Products | Jun 1, 2012 | Cancer, Miscellaneous |
Insight Genetics and Kindstar Globalgene (Beijing) Technology Inc are partnering to enhance cancer care in the Peoples Republic of China and surrounding regions.
Read MorePosted by Clinical Lab Products | May 6, 2012 | Cancer |
Judy O’Rourke As I’m writing, it was reported that Hologic Inc, Bedford, Mass, plans to purchase Gen-Probe, San Diego, for about $3.7 billion in cash. The Wall Street Journal had previously reported Hologic’s interest in expanding its
Read MorePosted by Clinical Lab Products | May 1, 2012 | Molecular Diagnostics |
The increasing role of pathology with companion diagnostics
Read MorePosted by Clinical Lab Products | Apr 24, 2012 | Cancer, Miscellaneous, Pancreatic |
One hundred and five US-based medical oncologists were surveyed about their current and expected treatment patterns in one of the largest oncology indications.
Read More